Interventional Targeting of the IRE1alpha-TGFbeta signaling loop in pulmonary fibrosis
肺纤维化中 IRE1α-TGFβ 信号环路的介入靶向治疗
基本信息
- 批准号:10318632
- 负责人:
- 金额:$ 69.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-15 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AerosolsApoptosisBleomycinCell DeathCell Differentiation processCellsCessation of lifeClinical ResearchCollagenComplexDevelopmentDiseaseDoseEndoplasmic ReticulumEndoribonucleasesEpithelialEpithelial CellsEtiologyEventExcisionExtracellular MatrixExtracellular Matrix ProteinsFeedbackFibroblastsFibrosisFunctional disorderFutureGeneticHeat-Shock Proteins 90HomeostasisHomoHumanHyperactivityInjuryIntegral Membrane ProteinIntegrinsInterventionLeadLearningLimb structureLinkLungMediatingMembraneMessenger RNAMicroRNAsModelingModificationMolecular ChaperonesMusOralOutcomeOutputPathogenesisPathologicPathway interactionsPatientsPharmaceutical PreparationsPharmacologyPhenocopyPhosphorylationPhosphotransferasesPlayProductionProfibrotic signalProtein SecretionProteinsPulmonary FibrosisPulmonary SurfactantsRNA SplicingReceptor Serine/Threonine KinaseRegulationReportingResolutionRibonucleasesRoleSecretory CellSignal PathwaySignal TransductionSystemTGF Beta Signaling PathwayTestingTransforming Growth Factor betaTransforming Growth Factor beta ReceptorsUp-RegulationWorkXBP1 geneacronymsalveolar epitheliumattenuationbasebiological adaptation to stresscell injurydimerendoplasmic reticulum stressepithelial injuryexperienceidiopathic pulmonary fibrosisin vivoinsightkinase inhibitormouse modelnanomolarnovelnovel drug classnovel therapeuticspreventresponsesenescenceskillssmall moleculetherapeutic targettooltranscription factortransdifferentiation
项目摘要
PROJECT SUMMARY/ABSTRACT
In this MPI RO1 application, we show that high endoplasmic reticulum (ER) stress and dysregulated unfolded
protein response (UPR) signaling in lungs precedes development of fibrosis in murine models of pulmonary
fibrosis (PF)—similar changes have been reported in lungs of human patients with idiopathic pulmonary
fibrosis (IPF). We find that the pathognomonic features of these changes are due to hyperactive signaling by
IRE1α, an ER transmembrane protein containing bifunctional kinase/endoribonuclease (RNase) catalytic
activities. We have found that novel, small molecule UPR kinase inhibitors of IRE1α, called KIRAs (an acronym
for kinase-inhibiting RNase attenuators) reduce IRE1α's destructive UPR signaling and show potent anti-
fibrotic effects in ER-stressed lungs of mice. Thus, even as IRE1α emerges as a potential therapeutic target for
treating human patients suffering from IPF, the underlying mechanistic basis for the cytoprotective, anti-fibrotic,
efficacy of the KIRA compounds needs to be understood. Through this application, we propose to understand
the basis of the KIRA-mediated salutary effects on reducing lung epithelial injury, dysregulation, and death,
and also on reducing collagen overproduction by activated fibroblasts. The project is enabled by the
complementary skill sets of two labs (Papa and Sheppard) that together have found the UPR is wired through
a signaling loop that leads to classical TGF-β-induced, pro-fibrotic signaling in lungs. Thus, the mechanistic
understanding to be gained from the successful completion of the proposed studies promises to reveal new
nodes and targets for rational disease modification in idiopathic pulmonary fibrosis, a currently incurable
disease.
项目概要/摘要
在此 MPI RO1 应用中,我们展示了高内质网 (ER) 应激和失调
在小鼠肺纤维化模型中,肺部的蛋白质反应(UPR)信号先于纤维化的发展
纤维化(PF)——特发性肺纤维化患者的肺部也有类似的变化
纤维化(IPF)。我们发现这些变化的病理特征是由于过度活跃的信号传导所致
IRE1α,一种内质网跨膜蛋白,含有双功能激酶/核糖核酸内切酶 (RNase) 催化作用
活动。我们发现了 IRE1α 的新型小分子 UPR 激酶抑制剂,称为 KIRA(缩写
用于激酶抑制 RNase 衰减剂)减少 IRE1α 的破坏性 UPR 信号传导并显示出有效的抗-
内质网应激小鼠肺部的纤维化效应。因此,即使 IRE1α 成为潜在的治疗靶点,
治疗患有 IPF 的人类患者,这是细胞保护、抗纤维化、
需要了解 KIRA 化合物的功效。通过这个应用程序,我们建议了解
KIRA 介导的减少肺上皮损伤、失调和死亡的有益作用的基础,
以及减少活化的成纤维细胞过度产生胶原蛋白。该项目是由
两个实验室(Papa 和 Sheppard)的互补技能组合共同发现 UPR 是通过有线连接的
导致肺部经典 TGF-β 诱导的促纤维化信号传导的信号传导环路。因此,机械
从成功完成拟议研究中获得的理解有望揭示新的
特发性肺纤维化(目前无法治愈)的合理疾病调整的节点和目标
疾病。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Small molecule inhibition of IRE1α kinase/RNase has anti-fibrotic effects in the lung.
IRE1α 激酶/RNase 的小分子抑制具有抗肺纤维化作用。
- DOI:10.1371/journal.pone.0209824
- 发表时间:2019
- 期刊:
- 影响因子:3.7
- 作者:Thamsen,Maike;Ghosh,Rajarshi;Auyeung,VincentC;Brumwell,Alexis;Chapman,HaroldA;Backes,BradleyJ;Perara,Gayani;Maly,DustinJ;Sheppard,Dean;Papa,FerozR
- 通讯作者:Papa,FerozR
{{
                item.title }}
{{ item.translation_title }}
- DOI:{{ item.doi }} 
- 发表时间:{{ item.publish_year }} 
- 期刊:
- 影响因子:{{ item.factor }}
- 作者:{{ item.authors }} 
- 通讯作者:{{ item.author }} 
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ patent.updateTime }}
Feroz R Papa其他文献
Feroz R Papa的其他文献
{{
              item.title }}
{{ item.translation_title }}
- DOI:{{ item.doi }} 
- 发表时间:{{ item.publish_year }} 
- 期刊:
- 影响因子:{{ item.factor }}
- 作者:{{ item.authors }} 
- 通讯作者:{{ item.author }} 
{{ truncateString('Feroz R Papa', 18)}}的其他基金
Caraballo Diversity Supplement 093019
Caraballo 多样性补充剂 093019
- 批准号:10026554 
- 财政年份:2019
- 资助金额:$ 69.77万 
- 项目类别:
Drugs to combat ER stress-induced dysfunction of AECIIs/Sheppard
对抗 ER 应激引起的 AECIIs/Sheppard 功能障碍的药物
- 批准号:8401271 
- 财政年份:2012
- 资助金额:$ 69.77万 
- 项目类别:
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function
通过调节 Ire1Alpha 功能对 Beta 细胞进行细胞保护
- 批准号:7872760 
- 财政年份:2009
- 资助金额:$ 69.77万 
- 项目类别:
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function
通过调节 Ire1Alpha 功能对 Beta 细胞进行细胞保护
- 批准号:8695105 
- 财政年份:2009
- 资助金额:$ 69.77万 
- 项目类别:
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function
通过调节 Ire1Alpha 功能对 Beta 细胞进行细胞保护
- 批准号:8072535 
- 财政年份:2009
- 资助金额:$ 69.77万 
- 项目类别:
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function
通过调节 Ire1Alpha 功能对 Beta 细胞进行细胞保护
- 批准号:8274825 
- 财政年份:2009
- 资助金额:$ 69.77万 
- 项目类别:
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function
通过调节 Ire1Alpha 功能对 Beta 细胞进行细胞保护
- 批准号:8478087 
- 财政年份:2009
- 资助金额:$ 69.77万 
- 项目类别:
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function
通过调节 Ire1Alpha 功能对 Beta 细胞进行细胞保护
- 批准号:9280930 
- 财政年份:2009
- 资助金额:$ 69.77万 
- 项目类别:
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function
通过调节 Ire1Alpha 功能对 Beta 细胞进行细胞保护
- 批准号:7729655 
- 财政年份:2009
- 资助金额:$ 69.77万 
- 项目类别:
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function
通过调节 Ire1Alpha 功能对 Beta 细胞进行细胞保护
- 批准号:9065686 
- 财政年份:2009
- 资助金额:$ 69.77万 
- 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:10585802 
- 财政年份:2023
- 资助金额:$ 69.77万 
- 项目类别:
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:10719415 
- 财政年份:2023
- 资助金额:$ 69.77万 
- 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:10605856 
- 财政年份:2023
- 资助金额:$ 69.77万 
- 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:23K08773 
- 财政年份:2023
- 资助金额:$ 69.77万 
- 项目类别:Grant-in-Aid for Scientific Research (C) 
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:23K15866 
- 财政年份:2023
- 资助金额:$ 69.77万 
- 项目类别:Grant-in-Aid for Early-Career Scientists 
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:10743485 
- 财政年份:2023
- 资助金额:$ 69.77万 
- 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:10749797 
- 财政年份:2023
- 资助金额:$ 69.77万 
- 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential  and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:22K09076 
- 财政年份:2022
- 资助金额:$ 69.77万 
- 项目类别:Grant-in-Aid for Scientific Research (C) 
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:10583516 
- 财政年份:2022
- 资助金额:$ 69.77万 
- 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:RGPIN-2019-05371 
- 财政年份:2022
- 资助金额:$ 69.77万 
- 项目类别:Discovery Grants Program - Individual 

 刷新
              刷新
            
















 {{item.name}}会员
              {{item.name}}会员
            



